|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Inflammatory Bowel Disease
Datamonitor, March 2011, Pages: 32
Introduction
Since the 1950s, the incidence of inflammatory bowel disease has substantially increased worldwide. However, over the last two decades, incidence of IBD has started to stabilize in the West suggesting a peak in incidence has been reached. In 2009, in the seven major markets there were 890,000 men and women with Crohn’s disease—over half (58%) of these were in the US. Furthermore, during the same y
Features and benefits
- - Gain insight to market potential, including a robust 10-year epidemiology forecast of Crohn’s disease and ulcerative colitis prevalent cases.
- Gain insights into the current and future prevalent trends of Crohn’s disease and ulterative colitis in the next 10 years
- Understand the key epidemiologic risk factors associated with inflammatory bowel diseases.
Highlights
- Since the 1950s, the overall incidence of IBD has gradually increased, although the increase in the incidence of ulcerative colitis (UC) precedes the increase in Crohn’s disease (CD) by approximately 15–20 years.
- The major risk factors IDB are largely unknown although environmental and genetic factors are thought to be important in the etiology of IBD.
- Across the seven major markets, Datamonitor estimates that in 2009 there were approximately 890,000 and 1.4 million prevalent cases of Crohn’s disease and ulcerative colitis, respectively.
Your key questions answered
- How will the IBD patient population change over the next decade in the seven major markets
- What are the estimated prevalent cases of Crohn’s disease and ulcerative colitis in the seven major markets
|
|
|
|
